Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Neuropathol Appl Neurobiol ; 33(4): 440-54, 2007 Aug.
Article de Anglais | MEDLINE | ID: mdl-17617873

RÉSUMÉ

Glioblastoma multiforme (GBM) and other high-grade brain tumours are typically characterized by complex chromosome abnormalities and extensive intratumour cytogenetic heterogeneity. The mechanisms behind this diversity have been little explored. In this study, we analysed the pattern of chromosome segregation at mitosis in 20 brain tumours. We found an abnormal segregation of chromatids at mitosis through anaphase bridging (10-25% of anaphase cells) in all 10 GBMs. Anaphase bridging was also found in two medulloblastomas (7-15%), one anaplastic astrocytoma (17%) and one oligodendroglioma (6%). These tumours showed a relatively high degree of cytogenetic complexity and heterogeneity. In contrast, cell division abnormalities were not found in low-grade brain tumours with less complex karyotypes, including two pilocytic astrocytomas and two ependymomas. Further analysis of two GBMs by fluorescence in situ hybridization with telomeric repeat probes revealed excessive shortening of TTAGGG repeats, indicating dysfunctional protection of chromosome ends. In xenografts established from these GBMs, there was a gradual reduction in cytogenetic heterogeneity through successive passages as the proportion of abnormally short telomeres was reduced and the frequency of anaphase bridges decreased from >25% to 0. However, bridging could be reintroduced in late-passage xenograft cells by pharmacological induction of telomere shortening, using a small-molecule telomerase inhibitor. Telomere-dependent abnormal segregation of chromosomes at mitosis is thus a common phenomenon in high-grade brain tumours and may be one important factor behind cytogenetic intratumour diversity in GBM.


Sujet(s)
Tumeurs du cerveau/génétique , Tumeurs du cerveau/anatomopathologie , Appareil du fuseau/anatomopathologie , Télomère/anatomopathologie , Adulte , Sujet âgé , Animaux , Tumeurs du cerveau/ultrastructure , Cellules cultivées , Enfant , Enfant d'âge préscolaire , Chromatides/génétique , Ségrégation des chromosomes/physiologie , Femelle , Humains , Immunohistochimie , Hybridation fluorescente in situ , Mâle , Souris , Souris de lignée NOD , Souris SCID , Adulte d'âge moyen , Transplantation tumorale , Phénotype , Échange de chromatides soeurs/génétique , Appareil du fuseau/ultrastructure , Telomerase/antagonistes et inhibiteurs , Telomerase/métabolisme , Télomère/ultrastructure , Transplantation hétérologue
2.
Cytogenet Genome Res ; 114(3-4): 257-62, 2006.
Article de Anglais | MEDLINE | ID: mdl-16954663

RÉSUMÉ

Epithelial tumour karyotypes are often difficult to study by standard cytogenetic methods because of poor chromosome preparation quality and the high complexity of their genomic rearrangements. Subtelomeric fluorescence in situ hybridisation (FISH) has proved to be a useful method for detecting cryptic constitutional chromosomal rearrangements but little is known about its usefulness for tumour cytogenetic analysis. Using a combination of chromosome banding, multicolour karyotyping and subtelomeric FISH, five colorectal cancer cell lines were characterised. The resulting data were compared to results from previous studies by comparative genomic hybridisation and spectral karyotyping or multicolour FISH. Subtelomeric FISH made it possible to resolve several highly complex chromosome rearrangements, many of which had not been detected or were incompletely characterised by the other methods. In particular, previously undetected terminal imbalances were found in the two cell lines not showing microsatellite instability.


Sujet(s)
Cassure de chromosome , Cartographie chromosomique , Tumeurs colorectales/génétique , Télomère/génétique , Lignée cellulaire tumorale , Zébrage chromosomique , Cassure de chromosome/génétique , Réarrangement des gènes/génétique , Humains , Hybridation fluorescente in situ/méthodes , Caryotypage
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...